Latest Proteasome Stories
Scientists have discovered a small molecule that helps human cells get rid of the misfolded, disfigured proteins implicated in AlzheimerÂ¹s disease and other neurodegenerative ailments.
Chemists at the University of California, San Diego, have identified how a protein that accumulates in the brains of people with Alzheimer's disease interferes with the ability of cells to get rid of debris.
EMERYVILLE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd.
EMERYVILLE, Calif., Sept. 7 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Monday, September 13, 2010 at 10:20 a.m. Eastern Time (7:20 a.m.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have uncovered the genes that regulate MDM2, an oncogene that, in turn, regulates the tumor suppressor protein p53.
EMERYVILLE, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Canaccord Genuity 30th Annual Growth Conference on Tuesday, August 10, 2010 at 8:00 a.m. Eastern Time (5:00 a.m.
A new study by researchers from the John Theurer Cancer Center at Hackensack University Medical Center sheds light on how bortezomib (VELCADEÂ®), the first in a new class of cancer drugs known as proteasome inhibitors, works in mantle cell lymphoma.
SAN DIEGO, June 22 /PRNewswire/ -- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery and development from marine microbial sources, announced completion of enrollment in the randomized Phase 2 ADVANCE study evaluating its tumor selective vascular disrupting agent (VDA), plinabulin (NPI-2358), in patients with non-small cell lung cancer (NSCLC) who have failed treatment with chemotherapy.
Pulmonary arterial hypertension (PAH) is a progressive disease, marked by shortness of breath and fatigue which can be fatal if untreated.
EMERYVILLE, Calif., June 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at Goldman Sachs 31st Annual Global Healthcare Conference on Tuesday, June 15, 2010 at 4:55 p.m. Eastern Time (1:55 p.m. Pacific Time).
- An armed gangster.